Skip to main content

Large Scale Biology to Expand Proteomics Facility

NEW YORK, Dec 7 - Large Scale Biology said Thursday that it expects to complete its new 53,000 sq ft proteomics facility in Germantown, Md., in the first quarter of 2001.

According to LSBC, the new facility will be the world's most highly automated center dedicated to quantitative proteomics.

The company plans to use the facility to extend its core proteomics platform, the ProGEx robotic system, and use it to create new database products for disease and drug effects. In a statement, Leigh Anderson, president of LSBC's proteomics subsidiary, noted that the ProGEx provides one million protein measurements per week.

“By the end of this year, we will have successfully completed the first version of the Human Protein Index, the protein equivalent of the human genome sequence,” Anderson said.

The facility will include ion trap mass spectrometry systems provided by Thermo Finnegan and MALDI MS systems provided by Bruker Daltonics  

" Proteomics is core to the discovery of breakthrough drug targets and disease markers for our partners, as well as to our internal development plans,” said Robert Erwin, CEO of LSBC, in a statement.  

The company was not immediately available for further comment.

The Scan

UK Funds to Stay Ahead of Variants

The UK has announced a further £29.3 million to stay on top of SARS-CoV-2 variants, the Guardian reports.

Push for Access

In a letter, researchers in India seek easier access to COVID-19 data, Science reports.

Not as Cold

Late-stage trial results are expected soon for an RNA-based vaccine that could help meet global demand as it does not require very cold storage, the New York Times writes.

Genome Research Papers on Microbes' Effects on Host Transfer RNA, Honeybee Evolution, Single-Cell Histones

In Genome Research this week: influence of microbes on transfer RNA patterns, evolutionary relationships of honeybees, and more.